| IPCA LABORATORIES  Back to Balance Sheet | 
IPCA LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,384 Cr | ₹2,356 Cr | ₹1,806 Cr | ₹1,466 Cr | ₹1,161 Cr | 
What is the latest Total Current Liabilities ratio of IPCA LABORATORIES ?
| Year | Total Current Liabilities | 
|---|---|
| Mar2025 | ₹2,384 Cr | 
| Mar2024 | ₹2,356 Cr | 
| Mar2023 | ₹1,806 Cr | 
| Mar2022 | ₹1,466 Cr | 
| Mar2021 | ₹1,161 Cr | 
How is Total Current Liabilities of IPCA LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,384 Cr | 1.22 | |
| Mar2024 | ₹2,356 Cr | 30.45 | |
| Mar2023 | ₹1,806 Cr | 23.19 | |
| Mar2022 | ₹1,466 Cr | 26.31 | |
| Mar2021 | ₹1,161 Cr | - | |
Compare Total Current Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹32,694.3 Cr | 1.6% | -2.4% | -18.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹408,751.0 Cr | 0.2% | 7.1% | -7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,634.0 Cr | 1% | 16.8% | 12.7% | Stock Analytics | |
| CIPLA | ₹124,437.0 Cr | -2.7% | 3.5% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,871.0 Cr | 0.6% | 0.4% | 4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,333.0 Cr | -6.4% | -2.7% | -3.9% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| IPCA LABORATORIES | 1.6% | -2.4% | -18.6% | 
| SENSEX | -0.2% | 5% | 5.4% | 
You may also like the below Video Courses
 
                     
                                     
                                     
                                    